by The Associated Press
Last Updated Jan 29, 2021 at 4:10 pm ADT
NEW YORK The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.
Week of Feb. 1
Atotech – Berlin, Germany, 34.1 million shares, priced $19-$22, managed by Citi/Credit Suisse. Proposed NYSE ATC. Business: Carlye-backed specialty chemicals company carved out of Total.
Evaxion Biotech – Copenhagen, Denmark, 2.8 million shares, priced $10-$12, managed by Oppenheimer & Co/Ladenburg Thalmann. Proposed Nasdaq symbol EVAX. Business: Danish Phase 1/2 biotech using AI to develop immuno-ocology therapies.
Landos Biopharma – Blacksburg, Va., 6.3 million shares, priced $15-$17, managed by JP Morgan Stanley/Jefferies. Proposed Nasdaq symbol LABP. Business: Phase 2 biotech developing oral small molecule therapies for autoimmune diseases.